Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib and Radiation in Pediatric Brain Stem Tumors or Supratentorial Malignant Gliomas
NCT00042991Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2002
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in brainstem glioma, malignant glioma, sponsored by National Cancer Institute. Started Jul 2002; status: completed.
02
Drugs
03
Conditions
brainstem gliomamalignant glioma
Beyond the preview
Go deeper on NCT00042991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042991.